Topadur Pharma

Schlieren, Switzerland

Topadur Pharma is a biopharmaceutical company that develops healthcare drugs for the treatment of aging diseases and medical ailments.

$3.4M raised

Jun 2024

Venture - Series Unknown

Biotechnology Health Care Pharmaceutical

Top Investors

Innosuisse Oshen Korea Institute for Advancement of Technology

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Topadur Pharma

How much funding has Topadur Pharma raised?

Topadur Pharma has raised $3.4M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2024.

Who are Topadur Pharma's investors?

Topadur Pharma's investors include Innosuisse, Oshen, Korea Institute for Advancement of Technology.

Where is Topadur Pharma headquartered?

Topadur Pharma is headquartered in Schlieren, Switzerland.

What does Topadur Pharma do?

Topadur Pharma is a biopharmaceutical company that develops healthcare drugs for the treatment of aging diseases and medical ailments.

What stage is Topadur Pharma at?

Topadur Pharma is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 6, 2024.

MLA

"Topadur Pharma — Funding & Investors." VCBacked, June 6, 2024, https://www.vcbacked.co/company/topadur-pharma. Accessed July 1, 2026.

APA

VCBacked. (2024). Topadur Pharma — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/topadur-pharma

Wikipedia (cite web)

{{cite web |title=Topadur Pharma — Funding & Investors |url=https://www.vcbacked.co/company/topadur-pharma |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 6, 2024.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K